Filing Details
- Accession Number:
- 0001274644-17-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-28 16:06:35
- Reporting Period:
- 2017-03-28
- Filing Date:
- 2017-03-28
- Accepted Time:
- 2017-03-28 16:06:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274644 | Ocera Therapeutics Inc. | OCRX | Pharmaceutical Preparations (2834) | 631192270 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1619893 | Michael Byrnes | C/O Ocera Therapeutics, Inc. 525 University Avenue, Suite 610 Palo Alto CA 94301 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-28 | 3,000 | $1.28 | 13,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
